A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis

✍ Scribed by Chen, Xiao-Xiang; Dai, Qing; Huang, An-Bin; Wu, Hua-Xiang; Zhao, Dong-Bao; Li, Xing-Fu; Hu, Shao-Xian; Yang, Nan-Ping; Tao, Yi; Xu, Jian-Hua; Jiang, Lin-Di; Bao, Chun-De

• Book ID: 118791371
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 290 KB
• Volume: 32
• Category: Article
• ISSN: 0770-3198
• DOI: 10.1007/s10067-012-2096-z